Canada markets closed

Anavex Life Sciences Corp. (0HFR.L)

LSE - LSE Delayed Price. Currency in USD
Add to watchlist
3.8781+0.1681 (+4.53%)
At close: 06:57PM BST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.57
52-Week Change 3-43.99%
S&P500 52-Week Change 322.38%
52 Week High 310.4460
52 Week Low 30.0000
50-Day Moving Average 35.7899
200-Day Moving Average 37.2401

Share Statistics

Avg Vol (3 month) 37.78k
Avg Vol (10 day) 33.92k
Shares Outstanding 545.43M
Implied Shares Outstanding 6N/A
Float 879.52M
% Held by Insiders 13.14%
% Held by Institutions 131.96%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-20.70%
Return on Equity (ttm)-31.88%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-43.16M
Diluted EPS (ttm)-0.5790
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)143.76M
Total Cash Per Share (mrq)1.75
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)11.85
Book Value Per Share (mrq)1.65

Cash Flow Statement

Operating Cash Flow (ttm)-29.31M
Levered Free Cash Flow (ttm)-17.68M